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ABSTRACT 
Some of  the most rapidly-evolving fields of study in the medical 
and research communities presently are those which investigate our 
genetic code, the elements and factors that control the expression of 
our genetic code, as well as fields of study which analyze theories 
about an organisms’ physiology and phenotype from the information 
that both of the previous topics concomitantly provide. The work of the 
Milavetz lab, among many others, is striving to fill the gaps in 
knowledge about epigenetic regulation of biological processes – here 
by using the well-suited model virus, Simian Virus 40.  
It has for some time now been agreed upon that epigenetic 
modifications of histone proteins not only exists, but play a crucial role 
in biological processes related to the availability or condensation of 
genetic material. Certain modifications have continuously been shown 
to either silence or expose genes1,2. It has also been shown that these 
modifications are not static but in a dynamic state3. However, the 
details of how, when, and why changes in the epigenetic modifications 
on the histone tails occurs is still being investigated.  
xii 
 
This project is intended to explore the effect of novel sequence 
inserts into the SV40 genome related to the enhancer region, Sp1 
binding site, and late promoter. Specific variants of SV40 were created 
to contain either one or two copies of the enhancer region (T-129 and 
T-143 respectively), two copies in succession of the Sp1 site (RH-43), 
or a full late promoter region (T-165). Chromatin immunoprecipitation 
(ChIP) and real-time quantitative polymerase chain reaction (q-PCR) of 
the histone modifications H3K4me1/2/3, H3K9me1/2/3, H4K20me1 
and RNAPII were analyzed.  
We found that certain modifications were affected by each 
sequence addition – some by a notable increase and some by a 
notable decrease. While more data is needed to more wholly 
characterize this phenomenon, these are some of the first results 
indicating an association between the DNA sequence present and the 
regulation of epigenetic histone modifications. 
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CHAPTER I 
INTRODUCTION 
 Deoxyribonucleic acid, or DNA, has sometimes been 
referred to as the molecule of life. While many small molecules are 
essential in the biological interworkings which support life, DNA is 
considered especially important because it is the molecule that holds 
all of the information necessary for the making of the proteins that 
carry out the moment-to-moment interactions that define life, growth, 
development, and even death. Since the discovery of DNA in 1869 by 
Friedrich Miescher4, many great findings since then have led to a now 
widely accepted understanding of the structure of DNA itself and the 
process by which this genetic material is used to direct the formation 
of functional molecules. The Central Dogma of Molecular Biology1,5 
shows that the information encoded into strands of DNA are read by a 
collection of cooperating proteins to produce ribonucleic acid (RNA) in 
a process known as transcription. This RNA is ultimately read by 
another conglomeration of molecules to produce proteins by the 
process of translation (Figure 1). 
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Figure 1. Central Dogma of Molecular Biology5. 
Composition of DNA to form the Genome  
DNA is composed of two long chains of nucleotides. The 
nucleotides of one chain, or strand, of DNA are held together by 
covalent bonds of the sugar-phosphate backbone to which the 
nucleotides are attached. There are four types of nucleotides which 
link, in a complementary and antiparallel fashion, to nucleotides of the 
second DNA strand by hydrogen bonds. Figure 2 portrays how the 
building blocks of DNA come together. The connections of the two 
strands of DNA form a double-helical structure. This particular  
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Figure 2. The building blocks and structure of DNA1. Copyright 2008 
from Molecular Biology of the Cell, Fifth Edition by Alberts et 
al.  Reproduced by permission of Garland Science/Taylor & Francis 
LLC. 
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structure has characteristics that make it naturally advantageous for 
both protecting the integrity of the nucleotide sequence from damage 
while also presenting available binding sites for molecules essential to 
biological processes such as transcription or replication6. 
The entirety of the DNA sequence and thus all of the genetic 
material is collectively referred to as an organisms’ genome. This 
includes both protein-coding and non-coding sequences of DNA. The 
segments of the sequence of DNA which code for functional proteins 
are called genes. Although the human genome is approximated to 
contain between 20,000 and 25,000 genes, they make up a 
surprisingly small percentage of the total sequence – about 20% - 
while the actual sequences that code directly for proteins is only 
around 2-3%1,6. 
The enormity of the amount of genetic material present in a 
cell’s nucleus drives its need for orderly compaction. In humans, our 
genetic material is divided into a set of 23 chromosomes. Figure 3 
illustrates how genes are arranged within a particular chromosome. 
The figure also demonstrates how small a percentage of the genetic 
sequence is genes, and even smaller percentage is sequences that 
directly code for proteins. How then does a cell organize 3200 km of 
double-stranded DNA1 into a chromosome that is less than 10 µm? The 
answer is the nucleosome. 
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Figure 3. The arrangement of genes within a human chromosome1.  
 
 
Structure and Function of Nucleosomes 
 There are a variety of proteins that assist in the compaction of 
DNA into its higher order structures which are either histones or 
nonhistone chromosomal proteins. The term chromatin is used to 
describe the entire assembly of both the DNA and these two classes of 
proteins. DNA interacts with an arrangement of histone proteins to 
form the first level of compaction, the nucleosome (Figure 4).  
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Figure 4. The structure of histones in the nucleosome1. Copyright 2008 
from Molecular Biology of the Cell, Fifth Edition by Alberts et 
al.  Reproduced by permission of Garland Science/Taylor & Francis 
LLC. 
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The characteristics of the different types of histone proteins in the 
nucleosome show how they interact with one another, how they 
condense DNA, and as we will see later the role they play in 
determining gene expression. 
Eight subunits of 4 types of histones – two from each category of 
histone H2A, H2B, H3, and H4 – converge to form the disc-shaped 
protein core of the nucleosome. One-hundred and forty-seven base 
pairs of nucleotides wrap around this histone core almost twice and is 
held there by numerous, reversible interactions between the 
phosphodiester backbone of the DNA and the amino acid backbone of 
the histones. Also, the high number of basic side chains like lysine and 
arginine within the histones readily interact with the negatively 
charged DNA1. A fifth type of histone, H1, is a linker histone which 
binds to both the DNA as it comes off the nucleosome and the histone 
core itself, assisting in the directionality of the DNA to bind with the 
next core of histone proteins. Nucleosomes interdigitate further to 
compact DNA into the 30 nm chromatin fibers of chromosomes. 
 As mentioned previously, the interactions between DNA and 
histone proteins is reversible and in fact highly dynamic1,7. The cell has 
just as much need for the DNA to be uncondensed and exposed when 
replicating the genetic material or transcribing genes for protein 
production as it does for compaction to protect the integrity of the 
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genetic sequence and repress gene expression. Maintenance and 
control of the balance of appropriate response to the needs of the cell 
occurs mostly by means of epigenetic regulation1,6,7. 
Epigenetic Modifications Regulate Processing of Genetic Material 
Epigenetics is a relatively new perception in the history of 
biological concepts, however the inquiries it lends an understanding to 
have long perplexed scientists. With the extraordinary amount of 
genetic information and the remarkable expanses of similarity between 
and even among species, how is it that life takes on such varied form 
and function? 
The notion of epigenetics began forming over a century ago8 
with the idea that factors outside the genetic sequence alone could 
have an impact on gene expression. The word epigenetics itself relates 
to its mechanism in that the Greek prefix ‘epi’ means ‘upon’ or ‘over’9, 
here relating to its function upon or over the genetic sequence versus 
within1,8. It is now the understanding of the scientific community that 
epigenetic modifications play a crucial role in most biological processes 
by regulating gene expression8,10. 
The two known types of epigenetic modifications occur on the 
DNA itself – namely DNA methylation of cytosine residues – and on the 
N-terminal tails of the histone proteins of the nucleosome where a 
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multitude of modifications can occur at a variety of sites (Figure 5). A 
2007 review in Cell classified eight types of histone modifications and 
characterized their biological effect11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Histone tails and their epigenetic modifications1. Copyright 
2008 from Molecular Biology of the Cell, Fifth Edition by Alberts et 
al.  Reproduced by permission of Garland Science/Taylor & Francis 
LLC. 
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Acetylation, methylation, phosphorylation, ubiquitlyation, sumoylation, 
ADP ribosylation, deamination, and proline isomerization have been 
identified on specific residues. Table 1 list these modifications along 
with the particular residue it modifies and the current understanding of 
the biological process to which the modification relates. 
Simian Virus 40 
 Simian virus 40, short-handed to SV40, was discovered in 1960. 
Its native environment is in certain primate species where it typically 
does not cause physiological issues except in animals with immune 
system deficiencies13. It became a subject of interest in the following 
years as it was found in the injected form of the polio vaccine which 
the Centers for Disease Control estimates that as many as 98 million 
Americans received between the years of 1955 and 196314. While 
SV40 has not been proven to cause the formation of lesions or tumors, 
SV40 has been identified in certain types of human cancers in recent 
years15,16. Because of this association, an increase in research about 
the characteristics and life cycle of SV40 has ensued, resulting in a 
plethora of novel, useful information regarding not only tumorigenesis 
but biological phenomena like DNA replication and transcription as 
well13,15,17,18. 
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Table 1. Epigenetic modifications of histones and their biological 
effect12. 
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SV40 is categorized as a polyomavirus – small, contains DNA, 
and has the potential to cause tumors. Figure 6 diagrams the SV40 
genome along with the coded proteins that will be subsequently 
discussed. With no viral envelope, the capsid containing the 5243-base 
pair circular minichromosome enters the host cell via caveolin vesicle 
formation after the virion glycoprotein VP1 binds to MHC class 1 
receptors on the surface of the cell. Once inside the nucleus, RNA 
polymerase II (RNAPII) initiates early gene expression and the 
production of three tumor antigens: the important and multifunctional 
large T antigen (LT), small T antigen (ST), and the less understood 
17K T antigen. 
  
 
 
Figure 6. Simian Virus 40 
genome19,20. 
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Large T antigen has three distinctive regions to carry out its 
numerous functions. LT has been shown to inactivate cellular proteins, 
like p53, thereby preventing apoptosis or cell cycle arrest; bind to and 
recruit RNAPII and certain transcription factors essential for 
perpetuating transcription of the viral DNA to the origin of replication; 
as well as suppressing further early transcription and acting as a 
helicase in assisting directionality of RNAPII in the transcription of late 
genes21,22. The structure of LT is shown in Figure 7. 
 
 
Figure 7. Large T antigen of Simian Virus 4019. 
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Late transcription gives rise to the structural viral capsid proteins 
VP1, VP2, and VP3. All protein products of the SV40 genome return to 
the nucleus and come together to form new virions. VP1 represents a 
majority of the proteins making up the icosahedral-shaped SV40 
capsid and, as mentioned previously, is considered the dominant link 
between the virion and the new host cell membrane. 
Because of its similarity to eukaryotic regulation of gene 
expression and the fact that it relies completely on the host cell’s 
machinery, SV40 is a well-suited model for studying DNA replication, 
gene expression, and oncogenic transformation13,15,17,18,20 – and in the 
case of our lab, the epigenetic characteristics of these biological 
phenomena as well. Recent findings of this lab are continuing to 
elucidate connections between epigenetic markers, like acetylation and 
methylation, on specific lysine residues present within the tails of 
histones like H3 and H4 in the viral nucleosome, and their subsequent 
correlation with certain biological processes. For example, 
hyperacetylated histones H3 and H4 have been shown to be associated 
with p300 – a histone acetyl transferase – in the transcriptional 
complex23. It has long been accepted that p300 works directly with 
RNA polymerase II (RNAPII) in transcribing genetic material1,23, which 
therefore links the hyperacetylation of H3 and H4 with the biological 
process of transcription. The mono- and tri-methylation states of 
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histone H4 lysine 20 (H4K20me1 and H4K20me3, respectively) have 
been shown to be present at separate time points during the SV40 
infection18,24. Observed early in infection, H4K20me3 is thought to be 
associated with the uncoating of the virus. H4K20me1 is conversely 
found later on in the infection, both in replicating SV40 chromosomes 
(also referred to as minichromosomes) as well as the virions 
themselves suggesting a connection to encapsidation18. Most recently, 
we have published data that supports the existence of trans-
generational epigenetic regulation by SV4025. Along with this idea, we 
detected multiple distinct sets of histone modifications that occur 
together – which we termed an epigenome. Our lab has identified five 
epigenomes in SV40 minichromosomes25 that will be explored as to 
their relation to certain biological processes as well. 
The focus of the research project for my thesis is centered on 
the question of whether the epigenetic patterns we have noted to be 
present within the SV40 virus are a sequence-dependent phenomenon 
or a result of the initiation of a certain biological process like active 
transcription. 
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CHAPTER II 
METHODS 
Cell Culture 
The cells used for infections to produce the viral chromatin used 
in the experiments were African green monkey kidney BSC-1 cells 
obtained from American Type Culture Collection, Rockville MD, and 
held at 37° C in a Napco Model 6200 CO2 incubator. The media used to 
support the growth of the cells was minimum essential media (MEM) 
containing Earle’s salts and L-glutamine in a 500 ml bottle purchased 
from GIBCO, Invitrogen, supplemented with 5 mg/ml gentamicin 
reagent solution antibiotics and 50 ml fetal calf serum (FCS) containing 
growth factors, both also from GIBCO. The BSC-1 cells were 
maintained in Corning tissue culture flasks, Fisher Scientific Company, 
either 25 cm3 or 75 cm3 in size with approximately 10 ml or 20 ml FCS 
and antibody-supplemented MEM, respectively. Twenty-five cm3 flasks 
were generally used for HIRT preparations to check for efficiency of 
infections whereas 75 cm3 flasks were typically used for chromatin 
preparations – methodology presented in the following sections. 
Growing cells were subcultured in the sterile environment of a Nuaire 
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laminar air flow hood Model NU 425-400. The refrigerated, 
supplemented MEM and frozen bottle of trypsin-EDTA .05% 
dissociation reagent, also from GIBCO, were warmed to room 
temperature in a Stovall gyrating hybridization water bath. Then, the 
flask of cells was checked by an Olympus light microscope to ensure a 
confluent monolayer of cells present. The flasks were placed in the 
hood where all remaining manipulations were conducted to ensure 
sterility. The caps of the flasks were wiped with an Fisherbrand sterile 
alcohol prep pad. The bottles and caps of the supplemented MEM and 
trypsin-EDTA were also wiped with an alcohol prep pad. New 25 cm3 or 
75 cm3 flasks for cell expansion were prepared with the addition of 
approximately 10 ml or 20 ml of fresh media, respectively. The media 
of the flask containing the confluent monolayer of cells was poured out 
into a waste flask. Using Fisherbrand 5 ml glass pipettes and rubber 
manual pipetter, 3 ml of trypsin-EDTA was added to the flask 
containing the cells to be removed. The trypsin wash was rotated over 
the cell layer manually for about 10 seconds to deactivate protease 
inhibitors within the MEM and then discarded into the waste flask. 
Using a new 5 ml pipette, 5 ml trypsin was added to the flask 
containing the cells to be removed and this time laid flat within the 
hood for approximately 1-2 minutes, allowing the trypsin to cover the 
cells for that time. The flask was then checked in the microscope to 
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approximate the level of detachment of the cells before a few gentle, 
manual taps were applied to the side of the flask to dislodge the cells 
completely. A new 5 ml pipette was used to remove 3 ml of the trypsin 
containing the now-detached cells and .5 ml was dispersed into each 
of six 25 cm3 flasks or 1 ml into each of three 75 cm3 flasks, all of 
which contain the appropriate amount of fresh media. Directly after 
the trypsin containing detached cells was dispersed to the new flasks, 
fresh MEM was added to the parent flask which still contains 2 ml 
trypsin and detached cells. Caps on all flasks were secured and then 
laid flat before returning to the CO2 incubator at 37° C. BS-C-1 cells 
expanded to confluent monolayers in 2-3 days on average, at which 
time they became ready for further subculturing or infection. 
Preparation of Stock Viral Material 
The wild-type 776 SV40 virus was a gift from Dr. Daniel 
Nathans. The parent variant in the experiment (T-129) was created by 
Dr. Barry Milavetz from a mutant of the 776 virus26, which was gift 
from Dr. Thomas Shenk. T-129 had a deletion of the enhancer region 
from nucleotide (nt) 128-200 and a deletion of the large T antigen 
region from nt 4739-4882. It also contained an inserted reporter 
segment with a polylinker at nt 2666 which contained sites recognized 
by restriction endonucleases MluI, ApaLI, PmlI, NciI, and BglI. The 
experimental constructs RH-43, T-143, and T-165 were prepared 
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previously in the Milavetz lab from the T-129 parent26,27. The variant 
RH-43 contained an addition of multiple Sp1 sites, the variant T-143 
included a second enhancer region, and the variant T-165 contained a 
full late promoter region (figures in results section). Stock of the 
different strains of virus were accumulated after 1 µl of the selected 
variant was placed into a flask containing a mono layer of the BSC-1 
cells and the supplemented media, and incubated until the virus had 
infected most cells and released additional virions into the media 
(approximately 10-14 days). The entire contents of the infected flask 
were collected in a Corning 50 ml flat cap tube until being aliquoted for 
subsequent infections. 
Infection of BSC-1 Cells 
Flasks containing confluent monolayers of cells ready for infection 
were moved from the sterile CO2 incubator to the virus incubator, a 
Napco Model 5100 CO2 incubator. A 500 ml bottle of GIBCO minimum 
essential media, unsupplemented and dedicated for use with viral 
infections, was also placed in the virus incubator to warm. Stock virus 
that has been consolidated and aliquoted into 1.5 ml Eppendorf tubes 
via the protocol in the section above was thawed per amount needed. 
Typically .5 ml virus was used with 4.5 ml of media from the 25 cm3 
flasks and 1 ml virus with 9 ml of media from the 75 cm3 flasks. Once 
ready for infection, the flasks were moved to the virus-dedicated 
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NuAire NU-425-400 isolation hood. The proper amount of media was 
poured off into a Corning 15 ml disposable flat-cap centrifuge tube 
(4.5 ml or 9 ml). The remaining media in the flask was poured into 
waste jars within the virus hood and the proper amount of media for 
the infection returned to the flask from the 15 ml centrifuge tube. The 
corresponding amount of virus was then placed into the proper flask 
with a virus-dedicated Gilson pipette man and TipOne pipette tips. 
Used tips were discarded in waste receptacle within virus hood. 
Immediately following the addition of the virus, the flasks were 
capped, laid flat, and rotated slightly to allow the virus to disperse 
evenly throughout the media and onto the cell layer. The flasks were 
incubated at 37° C for 30 minutes with the virus-media solution. At 
the end of 30 minutes, the virus-media solution was discarded from 
the flasks into the waste jars. The flasks were then washed twice with 
approximately 5 ml or 10 ml (for 25 cm3 flasks or 75 cm3 flasks, 
respectively) of the warmed, unsupplemented, virus-dedicated media 
by rotating the flasks in all directions to remove any remaining 
unbound virus from the inner surface of the flasks. The washes were 
discarded into the waste jars and any excess was pipetted out and also 
discarded. Next, 5 ml or 10 ml (for 25 cm3 flasks or 75 cm3 flasks, 
respectively) of the warmed, unsupplemented, virus-dedicated media 
was added to each flask. The flasks were then capped and placed back 
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into the 37° C virus incubator for 30 minutes or 48 hours, depending 
on the time-point of viral material needed. 
HIRT 
The HIRT method28 was used to determine whole-cell chromatin levels. 
First, the desired 25 cm3 flasks that had been infected with virus 30 
minutes or 48 hours previously were removed from the virus incubator 
and placed in the virus hood. The media was discarded into the waste 
jars. Dubecco’s Phosphate Buffered Saine (PBS) was used for two 
washes of the flasks using approximately 5 ml of PBS each time and 
rotating the flasks all directions to wash the entire inner surface of the 
flasks. The washes were discarded into the waste jars and any excess 
was pipetted out and also discarded. Once the washes have been 
completed and all PBS removed, 300 µl lysing solution was added to 
the flask (description of lysing solution can be found in Appendix B). 
The flask was then held flat and rotated so that the lysing solution 
covered the cell layer. The flask was continually rotated as the lysing 
solution thickened, at which point it was pipetted into a 1.5 ml 
Ependorf tube with a 101-1000 µl TipOne pipette tip and 10-1000 µl 
Gilson pipette man. Two-hundred microliters of PBS was used to rinse 
the sides of the flask, then pipetted off and added to the 1.5 ml 
Eppendorf tube. Next, 160 µl Sodium chloride was squirted into the 
1.5 ml Eppendorf tube being careful not to touch the pipette tip to the 
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sample. The sample was incubated overnight at 4°C, then spun at 
12000 x g for 30 minutes at 4°C in a Eppendorf Centrifuge, model 
5415C. The spin down formed a pellet of material at the bottom of the 
1.5 ml Ependorf tube which was either pulled out of the tube with a 
sterile wooden stick or the supernatant was carefully pipetted without 
disturbing the pellet and placed into another 1.5 ml Ependorf tube. The 
pellet was discarded. Samples were frozen at -20° C until ready for 
glassmilk preparation and quantitative real-time polymerase chain 
reaction (q-PCR), the protocols of which are in sections below. 
Nuclei Isolation 
The following procedure was used to isolate cellular nuclei for later 
extraction of viral chromatin material. In preparation, a set of one 15 
ml Corning flat-cap centrifuge tube and one 1.5 ml Ependorf tube per 
flask being harvested was filled as follows. Fourteen milliliters of nuclei 
preparation buffer (see Appendix B) was added to the 15 ml tube as 
well as 15 µl PMSF (Sigma), mixed gently, then 1 ml of the buffer plus 
PMSF was removed from the 15 ml tube and placed in the 1.5 
Ependorf tube. Both tubes were held at 4° C until ready for use in 
harvesting the cells. First, the desired 75 cm3 flasks that had been 
infected with virus 30 minutes or 48 hours previously were removed 
from the virus incubator and placed in the virus hood. The media was 
discarded into the waste jars. Dubecco’s Phosphate Buffered Saine 
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(PBS) was used for two washes of the flasks using approximately 10 
ml of PBS each time and rotating the flasks all directions to wash the 
entire inner surface of the flasks. The washes were discarded into the 
waste jars and any excess was pipetted out and also discarded. Once 
the washes were completed and all PBS has been removed, 1 ml of the 
buffer plus PMSF was taken from the 15 ml tube and added to the 
flask. The solution was rotated over the cell surface of the flask until 
completely covered with the liquid. A Fisherbrand disposable cell 
scraper was then used to gently remove the cells from the surface of 
the flask. Next, 1 ml 0.05% Triton X-100 (see Appendix B) was 
pipetted to wash the dislodged cells to the bottom of the flask where 
they were pipetted out and gently placed on top of the remaining 13 
ml of buffer plus PMSF in the 15 ml tube. Once all material from the 
flask was added to the 15 ml tube, it was centrifuged at 2500 rpm for 
10 minutes at 4° C in a Beckman J6-M1 centrifuge. The spin down 
formed a pellet of material at the bottom of the 15 ml tube. The 
supernatant was discarded and 100 µl of buffer plus PMSF from the 
1.5 ml Eppendorf tube was used to resuspend the pellet and transfer it 
gently to the top of the remaining buffer plus PMSF in the 1.5 ml 
Ependorf tube. This tube was centrifuged at 3000 x g for 10 minutes at 
4° C. The spin down again formed a pellet at the bottom of the 1.5 ml 
Eppendorf tube. The supernatant was removed without disturbing the 
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pellet. Finally, the pellet was frozen at -20° C overnight before 
performing extraction and gradient steps. 
Nuclear Extraction 
Nuclear extraction was performed to open up the nuclear envelope and 
separate chromatin from other nuclear material. The desired nuclear 
pellet was thawed then neutralized by resuspending with 75 µl 
chromosome extraction buffer (see Appendix B). The solution was 
vortexed (Lab-line Instruments, Inc.) for about 5 seconds and spun 
down at 12000 x g for 30 seconds at room temperature. The 
supernatant was pipetted off and discarded. Four-hundred microliters 
of chromosome extraction buffer was used to again resuspend the 
pellet. The Eppendorf tube was vortexed before holding at 4° C for 1 
hour. After this extraction period, the tube was centrifuged at 12000 x 
g for 10 minutes at 4° C. This spin down formed a pellet of material 
that was discarded once the supernatant was taken off and either 
transferred to a new, sterile 1.5 ml Eppendorf tube and frozen at -20° 
C until further use or immediately run on a gradient (see next section). 
Chromatin Gradient 
Glycerol gradients were used to purify DNA for use in chromatin 
immunoprecipitation (ChIP) protocols. The glycerol gradient was set up 
in a 1.5 ml Eppendorf microcentrifuge tube. Two-hundred microliters 
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of 50% glycerol (see Appendix B)were placed at the bottom of the 
tube. Next, 1 ml of 10% glycerol (see Appendix B) was gently added 
on top of the 50% glycerol base. The 400 µl of nuclear extraction 
product from the previous step was added gently on top of the 10% 
glycerol layer then centrifuged at 50,000 rpm for 35 minutes at 4° C in 
a TLA 100.3 rotor within a Beckman TLA 100 ultracentrifuge. Upon 
completion of the spin, 400 µl was carefully removed by pipette from 
the top-down and discarded. The next 600 µl from the top of the 
current level down was carefully removed and saved in a new, sterile 
and appropriately labeled 1.5 ml Eppendorf tube. The content of this 
sample was concentrated by glassmilk protocol and PCR-checked (see 
steps below) before use in ChIP assays. 
Chromatin Immunoprecipitation (ChIP) 
Chromatin immunoprecipitation assays use antibodies to pull down 
selected targets. The antibodies used in the experiments for this 
particular study were from Millipore, Active Motif, abcam, Upstate, and 
Santa Cruz Biotechnology. For our experiments, 7.8 µl of the selected 
antibody were added to an Eppendorf Protein LoBind tube along with 
170 µl protein agarose A and 750 µl ChIP dilution buffer from the 
Millipore ChIP kit. This solution was rotated continuously at 4° C for 
approximately 4 hours in a Labnet mini labroller. The tube was then 
centrifuged at 2000 rpm in the Eppendorf Centrifuge model 5415C at 
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room temperature for 1 minute to encourage the agarose to collect at 
the base of the tube. The supernatant was removed and discarded. 
Nine-hundred microliters of fresh ChIP dilution buffer from the exact 
same ChIP kit was again added to the tube containing the agarose 
along with 125 µl of the desired chromosomes that have previously 
been run on a gradient. This solution was rotated continuously at 4° C 
for approximately 12 hours. The tube was then centrifuged again at 
2000 rpm at room temperature for 1 minute to encourage the agarose 
to collect at the base of the tube. The supernatant was removed and 
discarded. A series of 5 different washes of the agarose from materials 
within the Millipore ChIP kit was performed in the following order: Low 
Salt, High Salt, Lithium chloride (LiCl), Tris-EDTA (TE) buffer, and Tris-
EDTA (TE) buffer again. For each wash, 750 µl of the specified solution 
was added to the tube containing the agarose, rotated continuously at 
4° C for 10 minutes, centrifuged at 2000 rpm at room temperature for 
1 minute to collect the agarose to the bottom of the tube, then the 
supernatant carefully removed and discarded. After the fifth and final 
wash and centrifugation, the supernatant was carefully taken off the 
agarose and discarded as usual. One-hundred and twenty-five 
microliters of fresh TE buffer was used to resuspend the agarose and 
transfer it to a clean, sterile 1.5 ml Eppendorf tube. Two sequential 15 
minute incubations at room temperature were conducted with 110 µl 
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SDS lysing buffer each time. At the end of 15 minutes, the agarose 
had again settled and the supernatant was carefully collected and 
saved in a new, sterile and appropriately labeled 1.5 ml Eppendorf 
tube. The collection of supernatant from the second SDS lysis buffer 
incubation was added directly to the first in the new tube. 
Concentrating with Glassmilk 
Before quantitating with real-time PCR, all samples were concentrated 
using GeneClean Spin Kit glassmilk kits from MP Biomedicals, LLC. All 
glassmilk steps were conducted within the sterile environment of an 
Air Clean 600 PCR workstation (ISC Bioexpress) using clean technique. 
Fifty microliters of glassmilk was placed in a sterile 1.5 ml Eppendorf 
tube, then 25 µl of the intended sample was gently mixed with the 
glassmilk using the suction of the pipette man. The glassmilk plus 
sample combination was allowed to sit for 10 minutes before being 
spun down for 90 seconds at room temperature in a Southwest 
Science microcentrifuge. The supernatant was carefully removed and 
discarded. An ethanol wash of 125 µl was added to the tube where 
pellet present was resuspended gently with the pipette man. The 
solution was allowed to sit briefly before being spun down again at the 
same conditions as previously done. The supernatant was again 
carefully removed and discarded. The pellet was dried for 15 to 20 
minutes, or until dry, in a Thermo Scientific Savant SPD Seppd Vac 
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SPD 131DDA with RVT 4104 refrigerated vapor trap. Once completely 
dried, 25 µl TE buffer was added to the pellet. Samples were stored 
frozen at -20° C or PCR-ed immediately. 
Quantitative real-time Polymerase Chain Reaction (qPCR) 
All PCR preparation steps were conducted within the sterile 
environment of an Air Clean 600 PCR workstation using clean 
technique. The hood was first cleaned of possible contaminants using 
DNA Zap two-part solution from Ambion. A ‘master mix’ solution was 
prepared of 600 µl Bio-Rad SsoAdvanced SYBR green SuperMix; 585 µl 
clean, nuclease-free water from Ambion; and 6 µl of both the forward 
and reverse parts of a primer set. The primer set was designed by Les 
Kallestad in the Milavetz lab using Primer-BLAST within the National 
Center for Biotechnology Information’s website. The primers were of 
the promoter region with the sequences 5`TTG CAA AAG CCT AGG 
CCT CCA AA 3` and 5`TGA CCT ACG AAC CTT AAC GGA GGC 3`. The 
‘master mix’ was thoroughly vortexed before using and prepared 
immediately before being aliquoted and combined with a sample to be 
PCR-ed. Twenty-nine microliters of ‘master mix’ was placed into a VWR 
0.2 µl flat cap PCR tube. The glassmilk sample to be added was 
appropriately, manually agitated to form an evenly resuspended 
solution of the glassmilk within the TE buffer. Two microliters of this 
glassmilk-TE buffer solution was then immediately pipetted out with a 
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PCR-dedicated, sterile Gilson 0.1 – 2 µl pipette man and TipOne 
pipette tips, and added to the ‘master mix’ in the PCR tube. Samples 
were normally prepared in triplicate and quantitative real-time PCR 
was carried out using a Bio-Rad CFX Connect Real-Time System and 
the accompanying Bio-Rad CFX Manager 2.1 software. The cycle 
pattern was set up to begin with a 15 minute “hot start” of 95° C, then 
55 cycles of one minute at 95° C to one minute at 60° C followed by 
one minute at 72° C. The program also performed a melt curve 
analysis – heating from 65° C to 95° C in five second intervals – at the 
end of the 55 cycles of amplification which we referred to for quality of 
amplified sample. 
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CHAPTER III 
RESULTS 
Construction of SV40 Variants 
 The parent construct in the experiment, T-129, is a variant of 
the SV40 wild type virus which has a deletion of an intron from the 
large T antigen coding region (nt 4739-4882) and a deletion of one of 
the enhancers from the nucleosome free region near the origin of 
replication (nt 128-200). The T-129 construct also contains an input 
reporter region with a polylinker (nt 2666) that contains sites sensitive 
to restriction endonucleases Mlu I, Apa LI, Pml I, Nci I, Bgl II26,27. 
These sites allowed the insertion of the various sequences of interest 
producing the variants used in the experiment. Figure 8 diagrams the 
setup of the T-129 parent construct as well as three experimental 
variants. RH-43 contains an additional two copies of the Sp1 binding 
site (nt 40-59) between the Mlu I and Apa LI restriction sites. Variant 
T-143 contains the second enhancer region (nt 103-178), again 
between the Mlu I and Apa LI sites. The T-165 variant included the 
whole late promoter (nt 255-424) and was also positioned between the 
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same two restriction endonuclease sites as with the previously 
described variants. 
Quality Control of Virus, Infection, and Experimental Conditions 
 The parameters of the experiments conducted were controlled 
for as much as possible by conducting quality control checks for the 
infectivity of the virus variants, optimal infection conditions, as well as 
ideal ChIP conditions. Newly produced virus was checked by HIRT 
procedure along with q-PCR to ensure new batches of virus were 
comparably infective of cells. The amount of virus used in infections, 
 
Figure 8. SV40 parent variant, T-129, and experimental variants     
RH-43, T-143, and T-16526,27. 
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Figure 9. SV40 infection optimization. 
the length of time the cells are first exposed to the virus, and the age 
of the cells at the time of infection were compared. The data collected 
used wild-type SV40 virus (776) and shows that the highest amount of 
whole cell viral material for a 48 hour infection is initiated when the 
cells are approximately 2.5 days post subculture (Figure 9, top). The 
highest amount of viral chromatin obtained from a 48 hour infection 
occurs when the infection is initiated 4.5 days post subculture or later 
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(Figure 9, bottom). This information was considered for the infections 
used to produce the selected viral chromatin for the ChIP experiments. 
ChIP/q-PCR Reveal Changes in Ratios of Modifications Present 
 The ChIP experiments were carried out via protocols described in 
the methods section previously. After the ChIP products were 
subjected to q-PCR, statistics were used to calculate both the 
percentage of modified chromatin bound by the ChIP and the ratio of 
those percentages between the SV40 variants RH-43, T-143, and T-
165 and the parent virus T-129. Cycle thresholds produced by the 
software of the q-PCR system indicate the number of cycles completed 
when fluorescence of the incorporated SYBR green are first able to be 
detected. These cycle thresholds (Ct) were used to calculate the 
comparisons (Table 2).  
To compute the percentage of the input chromatin bound by the 
selected antibody, the Ct of the un-ChIPed input chromatin was 
subtracted from the Ct of the related ChIP product to give a Ct 
difference. Given that amplification by q-PCR reaction should yield 
twice the amount of product from each cycle, one divided by 2 to the 
power of the Ct difference revealed the percent of the whole input 
chromatin pulled down by the antibody (%) and inferring the  
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percentage of the input chromatin containing the particular histone 
modification. 
 The ratio of the amount of a certain modification seen in the 
ChIP products of the variants to that of the ChIP product of the T-129  
parent was calculated by dividing the percent (%) of a variant by the 
percent (%) of the T-129 parent within the same ChIP experiment. 
Average values of these computations are shown in Table 2. Ratios of 
close to 2 or higher indicate a prominent increase in the amount of the 
modification present as a result of the sequence addition of the 
variant. Ratios of down to 0.5 or less indicate a notable decrease in 
the amount of modification present as a result of the input sequence of 
the variant.  
The average ratios of the variants for the selected histone 
modifications from Table 2 was graphed to more readily display any 
notable changes (Figure 10). RH-43, the variant containing an input 
sequence of two Sp1 binding sites, saw a noteworthy increase in the 
amount of H3K4me1 compared to the T-129 parent. Distinguishable 
decreases in H3K9me2 and H4K20me1 modification were also 
observed for the RH-43 variant (Figure 10, top panel). T-143, having a 
reintroduced second enhancer region, showed a prominent increase in 
H3K4me3 while also displaying notable decreases in H3K9me2 and 
H4K20me1 (Figure 10, middle panel). T-165, the variant containing an  
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Figure 10. Ratios of the selected modifications present in SV40 
variants to the T-129 parent. 
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addition of the late promoter sequence, resulted in decreases in 
H3K9me1 and H3K9me2 as well (Figure 10, bottom panel). The green 
line on the graphs is intended to assist in distinguishing notable 
increases or decreases in the ratio of modifications present in the 
variant versus the T-129 parent. The error bars represent one 
standard deviation of the average ratio of the variant to T-129. In this 
set of experiments, the antibody to RNAPII is intended as an internal 
control as RNAPII is traditionally a good marker for active 
transcription. As it relates to this experiment, the ratio of RNAPII does 
not increase or decrease significantly for the RH-43 or T-165 variants 
but perhaps a slight increase in T-143 (Figure 10, middle panel). This 
may suggest that the additional enhancer sequence in the T-143 
variant could be associated with an increase in active transcription. 
However, more investigation is needed to confirm this observation. 
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CHAPTER IV 
DISCUSSION 
 From the results of the initial experiments conducted and shown 
here, we can conclude that the presence of specific sequences is 
associated with changes in the amounts of certain histone 
modifications seen on SV40 minichromosomes. Additionally, it is 
important to note that the sequences inserted into the respective 
variants are known to be associated with gene activation (Table 1). 
The Sp1 binding sites added to RH-43 bind Specificity Protein 1 – a 
transcription factor known to be involved in gene expression in early 
development1,29. The increase in the ratio of H3K4me1, a modification 
associated with gene activation (Table 1); as well as the decreases in 
H3K9me2 and H4K20me1, modifications associated with gene 
repression (Table 1), both suggest that the addition of sequences 
involved in transcription also affects the histone modifications related 
to that biological process. Similarly, enhancer regions – like the one 
added to variant T-143 – are segments of DNA that bind trans-acting 
factors and enhance gene transcription30,31. Therefore the increase in 
the ratio of H3K4me3, again a modification associated with gene 
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activation, and the decreases in the ratios of H3K9me2 and H4K20me1 
further support our hypothesis. The T-165 variant contained an 
additional late promoter, which is also a sequence involved in initiating 
the transcription of particular genes26. The decreased ratios of 
H3K9me2 and H3K9me3 provide continued support for the notion that 
sequences can drive epigenetic modification of histones. 
 An additional piece of information that can be deduced from the 
data is one which is also recently being supported in other literature. 
Since the discovery of the different modifications that can be present 
on histones, it was assumed that methylation of any state would serve 
essentially the same purpose1,32,33,34. Our data suggests this may not 
be the case and that different methylation states can be associated 
with the functioning of different sequences. The mono-methylated 
form of H3K4 was affected by the addition of Sp1 binding sites in RH-
43, but the di- and tri-methylated states were unaffected (Figure 10, 
top panel).With the T-143 variant and its addition of a second 
enhancer region, the tri-methylated state of H3K4 saw an increase, 
however the mono- and di-methylated states did not show change 
(Figure 10, middle panel). Even though the Sp1 binding site and 
enhancer regions of a DNA sequence have both been associated with 
gene transcription and all three methylated stated of H3K4 are 
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connected to gene activation (Table 1), the different methylated states 
appear to be regulated separately. 
 Our lab plans to continue investigating this phenomenon to 
better understand the maintenance and regulation of histone 
modifications and their biological relevance by experimenting with 
different sequence inputs to determine if other sequences have an 
effect on the amount of a particular modification present. We could 
also look into the outcome of the position of the input sequence within 
the SV40 genome to establish if there is a positional effect. There are 
also a multitude of antibodies to other histone modifications that can 
be tested. The overall aim of this and future research of epigenetic 
modifications is to better understand the mechanisms by which the cell 
controls, and the environment affects, gene expression. This 
information, we are already seeing, could ultimately have broad 
implications in the fields which study human diseases and 
development. 
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Appendix A 
Commonly Used Abbreviations 
DNA     deoxyribonucleic acid 
RNA     ribonucleic acid 
RNAPII    ribonucleic acid polymerase II 
H3K4     histone 3 lysine 4 
H3K9     histone 3 lysine 9 
H4K20    histone 4 lysine 20 
me1     monomethyl 
me2     dimethyl 
me3     trimethyl 
km     kilometers 
nm     nanometers 
μm     micrometers 
SV40     Simian virus 40 
LT     large T antigen 
°C     degrees Celsius 
cm3     cubic centimeters 
L     liters 
ml     milliliters 
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µl     microliters 
nt     nucleotide 
Sp1     Specificity protein 1 
PBS     Phosphate Buffered Saline 
PMSF     phenylmethylsulfonyl fluoride 
x g     gravity constant 
ChIP     Chromatin immunoprecipitation 
q-PCR quantitative real-time polymerase chain 
reaction 
g     grams 
M     molar 
mM     millimolar 
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Appendix B 
Solutions and Buffers 
Lysing solution (HIRT) 6.0 ml 10% SDS, 2.0 ml 0.1 M EDTA, 
add Milli-Q water to 100 ml 
 
10% SDS 100 g SDS, add Milli-Q water to 1.0 L 
 
0.1 M EDTA (pH 8.0) 3.8 g EDTA, add water to 100 ml 
 
Milli-Q water Water purified by Milli-Q Water 
Purification System (Millipore) 
 
Sodium chloride (HIRT) 292.2 g NaCl, add Milli-Q water to 1 L 
 
Nuclei Preparation 50 ml glycerol (5%), 0.84 g HEPES (2 
Buffer (pH 7.4) nM), 5 ml 0.1 M MgCl2 (0.2 mM), 5 ml 
0.1 M PMSF* (0.5 mM), 5 ml 0.1 M DDT* 
(0.5 mM), add Milli-Q water to 1 L; 
autoclave sterilize 
 *add after autoclaving, filter sterilize 
 
0.1 M MgCl2 2.03 g MgCl2 : 6 H20, add water to 100 
ml 
 
0.1 M PMSF 1.74 g PMSF, add ethanol to 100 ml 
 
0.1 M DDT 0.77 g DDT, add water to 50 ml 
 
0.05% Triton 50 ml Triton X-100, add water to 100 ml 
 
Chromosome Extraction 0.24 g HEPES (10 mM), 1 ml 0.1 M EDTA 
Buffer (pH 7.5) (1 mM), 0.5 ml 0.1 M DDT (0.5 mM), 0.1 
ml 0.1 M PMSF (0.1 mM), add Milli-Q 
water to 100 ml, filter sterilize 
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Chromatin Gradient 1.19 g HEPES (10 mM), 0.186 g KCl (5 
Solutions (pH 7.5) mM), 5 ml 0.1 M EDTA (1 mM), 1 ml 0.1 
M MgCl2 (0.2 mM), 2.5 ml 0.1 M DDT 
(0.5 mM), add 50 ml glycerol for 10% 
glycerol solution or 250 ml glycerol for 
50% glycerol solution, add water to 500 
ml, autoclave sterilize 
 
All glassware and solutions autoclaved in a Castle M/C 3500 Series 
Sterilizer (Gentige-Castle). All solutions adjusted to the indicated pH  
using either 6 M NaOH or 6 M HCl. 
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